Bleeding Risk under Oral Factor Xa Inhibitors: Meta-analysis of the randomized comparison with Vitamin K Antagonists and Meta-Regression analysis

• Main Authors: Nabila Ferahta (Author), Lukshe Kanagaratnam (Author), Moustapha Dramé (Author), Thomas Vogel (Author), Pierre-Jacques Ambrosi (Author), Pierre-Olivier Lang (Author)
• Format: Book
• Published: Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, 2017-07-10.
• Subjects: Research Article
• Online Access: Connect to this object online.

<p><strong>Background: </strong>Randomized trials have shown that oral direct factor Xa inhibitors (ODIXa) offer potential advantages over vitamin K antagonists (VKAs). It is however unclear whether the magnitude of their benefi t is similar at the current recommended doses.</p&...